BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 20872319)

  • 1. Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
    Aljada A; Dong L; Mousa SA
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1158-68. PubMed ID: 20872319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRTUIN 1: regulating the regulator.
    Zschoernig B; Mahlknecht U
    Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease.
    Gan L
    Drug News Perspect; 2007 May; 20(4):233-9. PubMed ID: 17637936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases.
    Marmorstein R
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):904-9. PubMed ID: 15506920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule regulation of Sir2 protein deacetylases.
    Grubisha O; Smith BC; Denu JM
    FEBS J; 2005 Sep; 272(18):4607-16. PubMed ID: 16156783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirtuins in aging and age-related disease.
    Longo VD; Kennedy BK
    Cell; 2006 Jul; 126(2):257-68. PubMed ID: 16873059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.
    Borra MT; Langer MR; Slama JT; Denu JM
    Biochemistry; 2004 Aug; 43(30):9877-87. PubMed ID: 15274642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assays for characterization of the Sir2 family of NAD(+)-dependent deacetylases.
    Borra MT; Denu JM
    Methods Enzymol; 2004; 376():171-87. PubMed ID: 14975305
    [No Abstract]   [Full Text] [Related]  

  • 9. The Sir2 protein family: A novel deacetylase for gene silencing and more.
    Shore D
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14030-2. PubMed ID: 11114164
    [No Abstract]   [Full Text] [Related]  

  • 10. Longevity research. Single signal unites treatments that prolong life.
    Strauss E
    Science; 2003 May; 300(5621):881-3. PubMed ID: 12738822
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular physiology: Tuned for longer life.
    Turner R
    Nature; 2003 May; 423(6936):125. PubMed ID: 12736664
    [No Abstract]   [Full Text] [Related]  

  • 12. After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
    Huber K; Superti-Furga G
    Bioorg Med Chem; 2011 Jun; 19(12):3616-24. PubMed ID: 21306906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuin-independent effects of nicotinamide on lifespan extension from calorie restriction in yeast.
    Tsuchiya M; Dang N; Kerr EO; Hu D; Steffen KK; Oakes JA; Kennedy BK; Kaeberlein M
    Aging Cell; 2006 Dec; 5(6):505-14. PubMed ID: 17129213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal protection by sirtuins in Alzheimer's disease.
    Anekonda TS; Reddy PH
    J Neurochem; 2006 Jan; 96(2):305-13. PubMed ID: 16219030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin modulators: mechanisms and potential clinical implications.
    Sanchez-Fidalgo S; Villegas I; Sanchez-Hidalgo M; de la Lastra CA
    Curr Med Chem; 2012; 19(15):2414-41. PubMed ID: 22455589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins).
    Huber K; Schemies J; Uciechowska U; Wagner JM; Rumpf T; Lewrick F; Süss R; Sippl W; Jung M; Bracher F
    J Med Chem; 2010 Feb; 53(3):1383-6. PubMed ID: 20030343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function of sirtuins in biological tissues.
    Shoba B; Lwin ZM; Ling LS; Bay BH; Yip GW; Kumar SD
    Anat Rec (Hoboken); 2009 Apr; 292(4):536-43. PubMed ID: 19301279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity in the Sir2 family of protein deacetylases.
    Buck SW; Gallo CM; Smith JS
    J Leukoc Biol; 2004 Jun; 75(6):939-50. PubMed ID: 14742637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.
    Imai S; Armstrong CM; Kaeberlein M; Guarente L
    Nature; 2000 Feb; 403(6771):795-800. PubMed ID: 10693811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme.
    Avalos JL; Bever KM; Wolberger C
    Mol Cell; 2005 Mar; 17(6):855-68. PubMed ID: 15780941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.